Abnormal gut microbiota may cause PD-1 inhibitor-related cardiotoxicity via suppressing regulatory T cells
Abstract Treatment with PD-1 inhibitors may cause immune-related adverse events (irAE), of which PD-1 inhibitor-associated myocarditis is a rare and highly lethal irAE. However, the mechanism of PD-1 inhibitors-induced myocarditis in individuals with tumor is still unclear. Regulatory T cells (Treg)...
Saved in:
| Main Authors: | Huili Cao, Huwei Dai, Songshan Li, Zeeshan Afzal, Xinyan Wang, Zeyu Wen, Kaiyong Xiao, Yajing Zhao, Jin Li, Bin Yang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-07-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-05635-4 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Navigating Cardiotoxicity in Immune Checkpoint Inhibitors: From Diagnosis to Long-Term Management
by: Simone Nardin, et al.
Published: (2025-07-01) -
Immune checkpoint inhibitor myocarditis: a systematic case study
by: E. A. Kushnareva, et al.
Published: (2020-12-01) -
Cardiotoxicity mechanisms of antitumor therapy with immune checkpoint inhibitors: new achievements
by: L. D. Khidirova, et al.
Published: (2024-06-01) -
A review of immune checkpoint inhibitor-associated myocarditis: Epidemiology, pathogenesis, and biomarkers
by: Le Xu, et al.
Published: (2025-12-01) -
Development and validation of a multidisciplinary risk assessment scale for immune checkpoint inhibitor-associated myocarditis
by: Yanan DAI, et al.
Published: (2025-08-01)